Re:Build Manufacturing
The Head of Sales Programs & Collateral leads a small senior team to transform Re:Build's technical expertise into proposals, case studies, decks, and pitches that win complex B2B and B2G business. Reporting to the CMO, this role partners with strategic account managers and executive sales leadership to create data‑driven, persuasive sales enablement materials and AI‑enabled systems that accelerate deal cycles.
Headquarters
Framingham, Massachusetts, United States
Company Size
501-1000 employees
Founded
2020
Re:Build Manufacturing is an integrated design, engineering, and manufacturing company that helps organizations take innovative products from concept to full-rate production. Serving industries including Aerospace & Defense, Electrification, Energy & Environment, Medical, and Robotics & Automation, Re:Build partners with startups and established companies to solve complex, multi-disciplinary manufacturing challenges. With 450+ engineers, 14+ U.S. locations, and a 2.4 million square foot industrial footprint, the company delivers scalable, U.S.-based manufacturing solutions across demanding markets.
Re:Build Manufacturing Launches Ensorcell to Engineer and Manufacture Innovative and Affordable Life Science Tools
Nov 11, 2025
Re:Build Manufacturing achieves CMMC Level 2 certification
1 month ago
Re:Build Manufacturing at New Ken Advanced Manufacturing Park: Charting a course for American manufacturing, lifting up a community
Sep 4, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Re:Build Manufacturing.
23% above the average for this role
Foundation Alloy and Re:Build Manufacturing Launch Engineering Partnership to Fast-Track Scale-Up and Automation
Aug 28, 2025